Skip to main content
Clinical Trials/CTRI/2024/04/066470
CTRI/2024/04/066470
Not yet recruiting
未知

A Clinical Study to evaluate the skin irritation potential of Kerrato Hair Fibres on healthy human subjects. - NI

Scinuvo Consumer Products LLP0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Scinuvo Consumer Products LLP
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Scinuvo Consumer Products LLP

Eligibility Criteria

Inclusion Criteria

  • 1\)Gender: Non\-pregnant, non\-lactating female aged between 18 to 65\.
  • 2\)Subjects willing to give written informed consent
  • 3\)Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • 4\)Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • 5\)Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion Criteria

  • 1\. Pregnant or nursing mothers
  • 2\.Scars, excessive terminal hair or tattoo on the studied area
  • 3\.Henna tattoo anywhere on the body (in case of studies involving hair dyes)
  • 4\.Dermatological infection or pathology on the level of studied area
  • 5\.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye)
  • 6\.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
  • 7\.Chronic illness which may influence the outcome of the study
  • 8\.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
  • 9\.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial

Outcomes

Primary Outcomes

Not specified

Similar Trials